.png){kind=icon}
返回
Surface-engineered bacteria in drug development
.png){kind=icon}
OA
AI
DOI：10.1111/1751-7915.70033.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Bacterial surface display in combination with fluorescence-activated cell sorting is a versatile and robust system and an interesting alternative approach to phage display for the generation of therapeutic affinity proteins. The system enables real-time monitoring and sorting of cell populations, which presents unique possibilities for drug development. It has been used to develop several affibody molecules currently being evaluated preclinically for the treatment and diagnosis of, for example, cancer and neurodegenerative diseases. Additionally, it can be implemented in other areas of drug design, such as for mapping epitopes and evolving enzyme specificities. Bacterial surface display in combination with fluorescence-activated cell sorting is a versatile and robust system for the generation of therapeutic affinity proteins. It has been used to develop affibody molecules for the treatment and diagnosis of, for example, cancer and neurodegenerative diseases.image
Keyword:
AFFIBODY MOLECULES
STAPHYLOCOCCUS-CARNOSUS
TARGETING PROPERTIES
DISPLAY
PROTEIN
EXPRESSION
ANTIBODIES
BINDERS
LIBRARY
BINDING
期刊
IF:
5.2
论文数:
2.6K
被引数:
8.8K
机构
引用论文
How to do laparoscopic associating liver partition with portal vein ligation for staged hepatectomy
PREAI
分享收藏Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis.png)
MABS
OAAI
MABSIF7.3
OAAI分享收藏Novel affinity binders for neutralization of vascular endothelial growth factor (VEGF) signalingOAAI
OAAI分享收藏Optimization of electroporation-mediated transformation:: Staphylococcus carnosus as model organismOAAI
OAAI分享收藏
查看更多内容